ALY-302

N/A

Report date: 2025/02/06 14:58:22

Base Information

Drug NameALY-302
Drug Alias NameALY-302
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMastocytosis, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlys Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlys Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMastocytosis, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A